Predicting response to enzalutamide and abiraterone in metastatic prostate cancer using whole-omics machine learning

MLA

Anouk C. de Jong, et al. “Predicting Response to Enzalutamide and Abiraterone in Metastatic Prostate Cancer Using Whole-Omics Machine Learning.” Nature Communications, vol. 14, no. 1, Apr. 2023, pp. 1–19. EBSCOhost, https://doi.org/10.1038/s41467-023-37647-x.

APA

Anouk C. de Jong, Alexandra Danyi, Job van Riet, Ronald de Wit, Martin Sjöström, Felix Feng, Jeroen de Ridder, & Martijn P. Lolkema. (2023). Predicting response to enzalutamide and abiraterone in metastatic prostate cancer using whole-omics machine learning. Nature Communications, 14(1), 1–19. https://doi.org/10.1038/s41467-023-37647-x

Chicago

Anouk C. de Jong, Alexandra Danyi, Job van Riet, Ronald de Wit, Martin Sjöström, Felix Feng, Jeroen de Ridder, and Martijn P. Lolkema. 2023. “Predicting Response to Enzalutamide and Abiraterone in Metastatic Prostate Cancer Using Whole-Omics Machine Learning.” Nature Communications 14 (1): 1–19. doi:10.1038/s41467-023-37647-x.